| Conrad et al., “Efficacy of Aztreonam in the Treatment of Skeletal Infections Due to Pseudomonas aeruginosa,” Review of Infectious Diseases 13:S634-S639 (1991). |
| Cohn, et al., “The effect of amiloride on pigment expression in a clinical isolate of Pseudomonas aeruginosa,” Abstract, Apr. 1992, vol. 51, No. 4, pp. 562-567. |
| Molinari et al., “Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics,” J. Antimicorb. Chemother. 31:681-688 (1993). |
| Rahme et al., “Common Virulence Factors for Bacterial Pathogenicity in Plants and Animals,” Science 268:1899-1902 (1995). |
| Bloch et al., “Pathogenicity Island Evaluation in Escherichia coli K1 by Crossing with Laboratory Strain K-12,” Infection and Immunity 8:3218-3223 (1996). |
| Blum et al., “Gene Clusters Encoding the Cytotoxic Necrotizing Factor Type 1, Prs-fimbriae and α-Hemolysin form the Pathogenicity Island II of the Uropathogenic Escherichia coli Strain J96,” FEMS Microbiology Letters 126:189-195 (1995). |
| Carniel et al., “Characterization of a Large Chromosomal “High-Pathogenicity Island” in Biotype 1B Yersinia enterocolitica,” Journal of Bacteriology 178:6743-6751 (1996). |
| Censini et al., “cag, A Pathogenicity Island of Helicobacter pylori, Encodes Type I-Specific and Disease-Associated Virulence Factors,” Proc. Natl. Acad. Sci. USA 93:14648-14653 (1996). |
| Finlay et al., “Common Themes in Microbial Pathogenicity Revisited,” Microbiology and Molecular Biology Reviews 61:136-169 (1997). |
| Groisman et al., “Pathogenicity Islands: Bacterial Evolution in Quantum Leaps,” Cell 87:791-794 (1996). |
| Groisman et al., “How Salmonella became Pathogen,” Trends Microbiology 5:343-349 (1997). |
| Hacker et al., “Pathogenicity Island of Virulent Bacteria: Structure, Function and Impact on Microbial Evolution,” Molecular Microbiology 23:1089-1097 (1997). |
| Kovach et al., “A Putative Integrase Gene Defines the Distal End of a Large Cluster of ToxR-Regulated Coloization Genes in Vibrio cholerae,” Microbiology 142:2165-2174 (1996). |
| Lee. “Pathogenicity Islands and the Evolution of Bacterial Pathogens,” Infections Agents and Disease 5:1-7 (1996). |
| Mahairas et al., “Molecular Analysis of Genetic Differences between Mycobacterium bovis BCG and Virulent M. bovis,” Journal of Bacteriology 178:1274-1282 (1996). |
| Marschalek et al., “Tranfer RNA Genes: Landmarks for Integration of Mobile Genetic Elements in Dictyostelium discoideum,” Science 244:1493-1496 (1989). |
| Mel et al., “Modulation of Horizontal Gene Transfer in Pathogenic Bacteria by in Vivo Signals,” Cell 87:795-798 (1996). |
| Ochman et al., “Identification of a Pathogenicity Island required for Salmonella Survival in Host Cells,” Proc. Natl. Acad. Sci USA 93:7800-7804 (1996). |
| Rahme et al., “Use of Model Plant Hosts to Identify Pseudomonas aeruginosa Virulence Factors,” Proc. Natl. Acad. Sci. USA 94:13245-13250 (1997). |
| Ritter et al., “tRNA Genes and Pathogenicity Islands: Influence on Virulence and Metabolic Properties of Uropathogenic Escherichia coli,” Molecular Microbiology 17:109-121 (1995). |
| Shea et al., “Identification of a Virulence Locus Encoding a Second Type III Secretion System in Salmonella typhimurium,” Proc. Natl. Acad. Sci. USA 93:2593-2597 (1996). |
| Sorensen et al., “Phenazine Pigments in Pseudomonas aeruginosa Infection,” In: Pseudomonas aeruginosa as an Opportunistic Pathogen, Campa et al., eds., Plenum Press, New York, pp. 42-57 (1993). |
| Swenson et al., “Two Pathogenicity Islands in Uropathogenic Escherichia coli J96: Cosmid Cloning and Sample Sequencing,” Infection and Immunity 64:3736-3743 (1996). |
| Turner et al., “Occurence, Biochemistry and Physiology of Phenazine Pigment Production,” Advances in Microbial Physiology 27:210-275 (1986). |
Patent Grant
6355411
